The ratio of profit retained to profit after tax for public limited companies in the pharmaceutical industry for the 2012 to 2013 fiscal year

Annual · percent · 2010–2012 · Published by India — Reserve Bank of India

Latest · 2012

76.3%

up +1.0 pts vs 2011

High since 2010
76.3% · 2012
Low since 2010
73.2% · 2010

percent

Use this series in your AI

Use FactIQ to chart rbi::rbi|0221d2d875dfb035 over the last ten years, with its latest value and the change over the past year.

Paste into an AI model with FactIQ connected. How to connect

About this series

This series represents the financial ratio of profit retained relative to profit after tax for non-government non-financial public limited companies within the pharmaceutical industry. The data is based on Statement 12 of the Select Financial Ratios and refers to the historical fiscal year 2012-13. (Footnote: *=actual ratio; ^=average assets; **=profit-making-company subset; @=two-year-difference derived metric; # and -=missing token; row_markers=**)

Series ID
rbi::rbi|0221d2d875dfb035
Frequency
Annual
Units
percent
Coverage
2010 – 2012
The ratio of profit retained to profit after tax for public limited companies in the pharmaceutical industry for the 2012 to 2013 fiscal year: 76.3% for 2012 · FactIQ